We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+2.35%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24.3B
AUM Growth
-$663M
(-2.7%)
Cap. Flow
-$1.37B
Cap. Flow
% of AUM
-5.66%
Top 10 Holdings %
Top 10 Hldgs %
15.29%
Holding
1,567
New
158
Increased
553
Reduced
532
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$130M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$126M |
| 3 |
MetLife
MET
|
+$107M |
| 4 |
General Mills
GIS
|
+$92.4M |
| 5 |
Parker-Hannifin
PH
|
+$71.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$199M |
| 2 |
RTN
Raytheon Company
RTN
|
+$151M |
| 3 |
Delta Air Lines
DAL
|
+$148M |
| 4 |
Norfolk Southern
NSC
|
+$145M |
| 5 |
Boston Scientific
BSX
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.77% |
| 2 | Financials | 14.55% |
| 3 | Technology | 14.11% |
| 4 | Consumer Discretionary | 8.63% |
| 5 | Industrials | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Motorola Solutions
MSI
$77.6B
| $7.05M | 0.03% |
105,700
+35,900
| +51% | +$2.37M |
|
477
iShares S&P 100 ETF
OEF
$20.1B
| $7M | 0.03% |
77,502
-8,900
| -10% | -$810K |
|
|
PARA
478
DELISTED
Paramount Global Class B
PARA
| $6.95M | 0.03% |
114,575
+68,021
| +146% | +$3.97M |
|
479
Ameriprise Financial
AMP
$49.4B
| $6.92M | 0.03% |
52,900
+9,500
| +22% | +$1.25M |
|
480
iShares China Large-Cap ETF
FXI
$4.1B
| $6.92M | 0.03% |
155,850
+23,400
| +18% | +$996K |
|
|
WWAV
481
DELISTED
The WhiteWave Foods Company
WWAV
| $6.83M | 0.03% |
+154,000
| New | +$5.88M |
|
|
QGENF
482
DELISTED
QIAGEN NV
QGENF
| $6.82M | 0.03% |
270,419
-156,750
| -37% | -$3.95M |
|
483
DaVita
DVA
$12.2B
| $6.81M | 0.03% |
83,827
-18,850
| -18% | -$1.45M |
|
|
RPTP
484
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $6.78M | 0.03% |
624,131
+268,908
| +76% | +$2.74M |
|
|
ARRY
485
DELISTED
Array Biopharma Inc
ARRY
| $6.78M | 0.03% |
919,547
+64,941
| +8% | +$462K |
|
486
Agios Pharmaceuticals
AGIO
$1.96B
| $6.76M | 0.03% |
71,664
+5,061
| +8% | +$567K |
|
487
Nelnet
NNI
$4.56B
| $6.74M | 0.03% |
142,394
-4,806
| -3% | -$222K |
|
488
Ironwood Pharmaceuticals
IRWD
$671M
| $6.7M | 0.03% |
499,837
-57,621
| -10% | -$756K |
|
489
Ingles Markets
IMKTA
$1.57B
| $6.64M | 0.03% |
134,210
-1,241
| -0.9% | -$55.8K |
|
490
Vanguard S&P 500 ETF
VOO
$1.04T
| $6.63M | 0.03% |
35,070
+7,500
| +27% | +$1.42M |
|
|
HDS
491
DELISTED
HD Supply Holdings, Inc.
HDS
| $6.61M | 0.03% |
212,000
-214,800
| -50% | -$6.25M |
|
|
AKRX
492
DELISTED
Akorn Inc
AKRX
| $6.59M | 0.03% |
+138,650
| New | +$6.29M |
|
493
RLJ Lodging Trust
RLJ
$1.67B
| $6.56M | 0.03% |
209,600
+12,300
| +6% | +$407K |
|
494
NiSource
NI
$19.5B
| $6.55M | 0.03% |
377,434
-130,451
| -26% | -$2.21M |
|
495
iShares MSCI Pacific ex Japan ETF
EPP
$2.25B
| $6.53M | 0.03% |
144,004
-100,300
| -41% | -$4.53M |
|
|
MDSO
496
DELISTED
Medidata Solutions, Inc.
MDSO
| $6.52M | 0.03% |
133,000
-7,000
| -5% | -$324K |
|
497
iShares Morningstar Mid-Cap Growth ETF
IMCG
$3.96B
| $6.5M | 0.03% |
233,580
+212,400
| +1,003% | +$5.68M |
|
|
K
498
DELISTED
Kellanova
K
| $6.48M | 0.03% |
104,676
-286,618
| -73% | -$17.5M |
|
|
VRE
499
DELISTED
Veris Residential
VRE
| $6.48M | 0.03% |
336,147
+16,058
| +5% | +$310K |
|
500
M&T Bank
MTB
$34B
| $6.46M | 0.03% |
50,900
-1,600
| -3% | -$194K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2015 Portfolio in Review
As of Q1 2015, Axa held 1,567 positions worth $24.3B, down 2.7% from $24.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Axa withdrew a net $1.37B in Q1 2015, closing 145 positions and reducing 532 holdings. Its most notable exit was Viatris, an estimated $55.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Financials and Technology.
Against the trend, Axa opened a new position in Nasdaq worth $42.1M.
- Axa's largest Q1 2015 buy was Nasdaq: 2,480,223 shares worth $42.1M.
- Axa added most to Johnson & Johnson in Q1 2015, an estimated $130M increase.
- Axa's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $199M.
- Axa fully exited Viatris in Q1 2015, selling an estimated $55.8M.
- Axa's ten largest holdings make up 15% of its $24.3B portfolio in Q1 2015.
- Axa opened 158 new positions and closed 145 in Q1 2015.
- Axa's portfolio value fell 2.7% quarter-over-quarter to $24.3B.
Based on Axa's 13F filing for Q1 2015, filed 13 May 2015.